Endpoint Clinical

San Francisco, United States Founded: 2009 • Age: 17 yrs Acquired By Arsenal Capital Partners
Interactive Response Technology systems are provided for clinical trials.

About Endpoint Clinical

Endpoint Clinical is a Healthcare company based in San Francisco (United States) founded in 2009, and was acquired by Arsenal Capital Partners in March 2024. Interactive Response Technology systems are provided for clinical trials. The company has 172 employees. Its website endpointclinical.com draws about 43 thousand monthly visits. Its Indian entity Endpoint Eclinical India Private Limited reported revenue of β‚Ή34.26 Cr. Endpoint Clinical offers products and services including PULSE and Elosity. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Korio, Mosiac InVivo and Clinapps; 1 of its 3 listed competitors has raised funding.

Company details

Endpoint Clinical was founded in 2009 in San Francisco, United States, and operates within the clinical trials sector. A proprietary Interactive Response Technology platform known as PULSE is utilized to deploy systems for randomization, subject management, site and study oversight, drug supply handling, ePro, and regulatory compliance through a quality management system. The platform can also be licensed as a software-as-a-service solution for client-configured deployments.

Key Metrics
  • Indian entity revenue
    ₹34.26 Cr

    FY 2025 · +13% YoY

  • Indian entity net profit
    ₹3.90 Cr

    FY 2025 · 11% margin

  • Indian entity EBITDA
    ₹5.93 Cr

    FY 2025 · 17% margin

  • Latest Funding Round
    $1.7M (USD), Debt – Conventional

    Mar 2010

  • Investors
  • Employee Count
    172
  • Acquired by

Products & Services of Endpoint Clinical

Endpoint Clinical offers a comprehensive portfolio of products and services, including PULSE and Elosity.

PULSE
RTSM Solution

Supports all study designs with configurable and pre-validated components.

Elosity
RTSM Solution

Ensures seamless study start-up with elasticity and velocity features.

Funding Insights of Endpoint Clinical

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $1.7M
  • First Round $1.7M

    (Mar 2010)

All 1 funding rounds of Endpoint Clinical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2010$1.7MDebt – Conventional––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Endpoint Clinical

Endpoint Clinical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Arsenal Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investments target specialty industrials and healthcare sectors.
2000arsenalcapital.comNew York, United States
Premium access

Investor details for Endpoint Clinical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Endpoint Eclinical India Private Limited (Endpoint Clinical)

Endpoint Eclinical India Private Limited is the primary company behind Endpoint Clinical. The board of Endpoint Eclinical India Private Limited currently have 3 directors; the longest-serving is Mohit Agarwal, appointed in 2019. 12 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mohit Agarwal
DIN 08630567
Director27 Dec 20196 yrs 10 moEndpoint Eclinical India Private Limited
Sandeep Thalla
DIN 08822840
Director25 Aug 20206 yrs 2 moEndpoint Eclinical India Private Limited
Aravind Ramachandran
DIN 06755913
Whole-time director22 Mar 20251 yr 7 moEndpoint Eclinical India Private Limited

People of Endpoint Clinical

66 people are tracked at Endpoint Clinical (19 in leadership, 47 in team); the tracked headcount is 172.

NameRoleGroup
Kristin Jordan
Senior Account DirectorLeadership
Kavitha Ganapa
Associate Director - Client ServicesLeadership
Rj Nofuente
Associate Director Operations Engineering (apac)Leadership
Julie Petrusa
Associate Director, Data ManagementLeadership
Wonna Louie
Head, Finance & AccountingLeadership
Adam Brand
Sr. Director of Account ManagementLeadership
Sri Kadari
VP, APAC OperationsLeadership
Christophe Deloison
Executive Director Leading Business Development For EMEA I APACLeadership
Cliff Edahl Jr.
Director, Business DevelopmentLeadership
Robert Baggerly
Director, Strategic Business DevelopmentLeadership
Amanda Sheldon
Director, Human Resources - Patient AccessLeadership
Umesh Jain
Head Of Data & AI SolutionsLeadership
Krystal Kermott
Executive Director, Business Development - US West And CRO ChannelLeadership
Jamie Read
Director, Global Business DevelopmentLeadership
Ajai Singh
Senior Director, Product EngineeringLeadership
John Jankowski
Head Of Information TechnologyLeadership
Praveen Kumar Saini
Senior Director Of Cloud ArchitectureLeadership
Nisha Nair
Associate DirectorLeadership
Geoff B. Seiff Pmp
Sr. Director, Hosting OperationsLeadership
Bhavin Patel
Lead Technical Software Test EngineerTeam

46 more people are available in the full profile.

Premium access

Complete people profiles for Endpoint Clinical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Endpoint Clinical

Figures of Endpoint Eclinical India Private Limited, the primary company behind Endpoint Clinical, for FY 2025. Revenue was ₹34.26 Cr (+13% year on year). Net profit was ₹3.90 Cr (11% margin). EBITDA was ₹5.93 Cr (17% margin). Revenue has grown at a compounded annual rate of +22% over three years and +22% over five years.

  • ₹34.26 CrRevenue · FY 2025 · +13% YoY
  • ₹3.90 CrNet profit · 11% margin
  • ₹5.93 CrEBITDA · 17% margin
  • ₹1 LakhPaid-up capital
  • 172Employees (provident fund records)
  • +22%Revenue CAGR, 3 years
  • +22%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Endpoint Eclinical India Private Limited are on its company page.

Premium access

Detailed financial statements for Endpoint Clinical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Endpoint Clinical

3 dated milestones of Endpoint Clinical across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Endpoint Clinical is founded.
  2. Funding First funding round of $1.7M.
  3. Exit Acquired by Arsenal Capital Partners.

Competitors of Endpoint Clinical

Endpoint Clinical has 3 listed competitors in our database, 1 of them funded. They include Korio, Mosiac InVivo and Clinapps.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
korioclinical.com2021San Francisco, United States$12.3M
Software for clinical trial supply management and randomization is provided.
mosaicinvivo.net2010San Jose, United States
Software solutions for pre-clinical scientific data management in life sciences.
clinapps.com1999San Diego, United States
Software products and services for the pharmaceutical and biotechnology industries
Premium access

Detailed competitors of Endpoint Clinical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Endpoint Clinical

The website of Endpoint Clinical (endpointclinical.com) receives about 43.5K visits a month and ranks #535,814 among all websites worldwide, #555 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    43.5K

    ▲ 11.4% vs previous month

  • Unique visitors
    11.8K

    per month

  • Global rank
    #535,814

    among all websites

  • Category rank
    #555

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Endpoint Clinical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
primaryendpoint.com
primaryendpoint.com
100%
–
fda.gov
67%
#7,606View details
endpointenvironmental.com
endpointenvironmental.com
40%
–
thefreedictionary.com
38%
4.3M#12,587View details
asent.org
28%
#7,906,509View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Endpoint Clinical (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Endpoint Clinical

Premium access

Complete news archive for Endpoint Clinical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Endpoint Clinical

Endpoint Clinical was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Endpoint Clinical is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Endpoint Clinical has 172 employees.

The primary company behind Endpoint Clinical, Endpoint Eclinical India Private Limited, reported revenue of β‚Ή34.26 Cr for FY 2025, up 13% year on year.

Endpoint Clinical was founded in 2009 in San Francisco, United States, and operates within the clinical trials sector. A proprietary Interactive Response Technology platform known as PULSE is utilized to deploy systems for randomization, subject management, site and study oversight, drug supply handling, ePro, and regulatory compliance through a quality management system. The platform can also be licensed as a software-as-a-service solution for client-configured deployments.

Endpoint Clinical's top competitors include Korio, Clinapps and Mosiac InVivo.

Endpoint Clinical offers PULSE and Elosity.

Endpoint Clinical has 1 investor. Key investors include Arsenal Capital Partners.

Endpoint Clinical operates through Endpoint Eclinical India Private Limited.

Yes. Endpoint Clinical was acquired by Arsenal Capital Partners in March 2024.

The legal entities of Endpoint Clinical currently have 3 directors, including Sandeep Thalla, Mohit Agarwal, Aravind Ramachandran.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available